C the Signs key facts
as of Oct 2026- Developer of a cancer detection platform intended to detect cancer at the curable stage.
- C the Signs is valued at approximately $31.8M as of Oct 2026 (last reported valuation).
- It has raised $21.0M; the latest was Later Stage VC ($8.0M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, Khosla Ventures, Tech Nation Group, Microsoft for Startups, Matter (Consulting Services (B2B)) — 15 tracked in total.
- Status: Privately Held (backing).
C the Signs's last reported valuation, Feb 2022. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch C the Signs: the Monday email on marks, rounds and moves
C the Signs funding rounds
No funding rounds for C the Signs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs C the Signs
15+C the Signs valuation
C the Signs's last reported valuation was $31.8 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.
C the Signs investors
15 investors are on record for C the Signs, including Plug and Play Tech Center, Khosla Ventures, Tech Nation Group and Microsoft for Startups.
About C the Signs
Developer of a cancer detection platform intended to detect cancer at the curable stage. The company's platform analyses data points, using a combination of clinical signs, symptoms, risk factors, and other markers, to spot cancer and its risk and fast-track them to an appropriate test or referral, enabling physicians to diagnose and treat cancer and reduce death rates.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 26
- Website
- cthesigns.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.